Loading organizations...

§ Venture Capital · United Kingdom
EIS and VCT fund manager investing growth capital in UK businesses across technology, healthcare, and creative industries.
Key people at Calculus Capital.
Calculus Capital is a London-based fund manager that specializes in Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) funds, providing growth capital to unlisted UK businesses across the technology, healthcare, and creative industries. The firm manages tax-efficient investment vehicles from individual investors to back early-stage companies demonstrating strong management and market potential. Additionally, the firm offers an Inheritance Tax Solution providing secured loans to film and television productions. The organization currently manages approximately £170 million in tax-efficient assets under management across its various funds, while its dedicated Calculus VCT holds £45.7 million in net assets distributed across 38 active portfolio companies. Its venture investments include recognizable emerging enterprises such as advertising agency Wonderhood, booking solutions provider Booked It, and gene therapy developer Laverock. Calculus Capital was founded in 1999 by John Glencross and Susan McDonald.
Calculus Capital is a UK-based investment firm specializing in tax-efficient venture capital funds, primarily operating within the Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) frameworks. Founded in 1999, it focuses on backing innovative companies across rapidly growing sectors such as technology, healthcare, and the creative industries. The firm aims to support companies driving innovation, advancing healthcare, and creating jobs, offering investment products like the Calculus EIS Fund and Calculus VCT to investors seeking exposure to small and unquoted UK companies[1][2][3][4].
The firm was co-founded by John Glencross (CEO) and Susan McDonald (Chairman), and has built a strong reputation as one of the longest-standing managers in the UK EIS and VCT space. Calculus Capital has a stable, experienced team and a disciplined investment and monitoring process, which has resulted in a track record of profitable exits and capital appreciation. It has made over 80 investments, including in companies like Booked it, a technology provider specializing in booking, CRM, marketing, and loyalty solutions, demonstrating its focus on scalable, mission-critical products in fast-growing markets[2][3][4].
Calculus Capital rides the trend of increasing demand for tax-efficient investment vehicles in the UK, particularly through EIS and VCT schemes, which incentivize investment in early-stage and growth companies. The timing is favorable due to growing innovation in technology, healthcare, and creative sectors, alongside government support for startup ecosystems. By channeling capital into these sectors, Calculus Capital helps fuel innovation, job creation, and economic growth, influencing the broader UK startup and scale-up ecosystem positively[1][3][4].
Looking ahead, Calculus Capital is likely to continue expanding its portfolio in high-growth sectors, leveraging its expertise in tax-efficient funds to attract investors. Trends such as digital transformation in healthcare, data-driven technology solutions, and creative industry innovation will shape its investment focus. The firm’s influence may grow as it supports companies that become market leaders, further solidifying its role as a key enabler of UK innovation and economic development[2][4].
In summary, Calculus Capital stands out as a pioneering, experienced investment firm dedicated to supporting innovative UK companies through tax-efficient funds, with a strong track record and a strategic role in advancing the UK’s technology, healthcare, and creative sectors.
Key people at Calculus Capital.
Calculus Capital has 9 tracked investments across 8 companies. The latest tracked deal is $8.1M Series A in Resurrect Bio in February 2026.